Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
Cochrane Reviews,  Clinical Article

Walters JAE et al. – The authors based assessment of the efficacy of short compared to longer duration systemic corticosteroid therapy for acute exacerbations of chronic obstructive pulmonary disease (COPD) in this review on four of the seven included studies for which data were available. The finding in this review that there is no significant increase in treatment failure with shorter systemic corticosteroid treatment for seven days or less for acute exacerbations of COPD, does not give conclusive evidence to recommend change in clinical practice due to a wide confidence interval around the estimate of effect.

Methods
  • The authors searched the Cochrane Airways Group Register of Trials (to April 2011) Cochrane Central Register of Controlled Trials (to April 2011), MEDLINE (from 1950 to October 2010), EMBASE (from 1980 to October 2010) and the reference lists of articles.
  • Randomised controlled trials comparing different durations of SC (seven days or fewer or more than seven days).
  • Other interventions, e.g. bronchodilators and antibiotics, were standardised; studies in other lung diseases were excluded, unless data on participants with COPD were available.
  • Two review authors independently extracted data that were pooled them using Review Manager 5.
  • The authors sought missing data from authors of studies published as abstracts only.

Results
  • The authors identified seven studies including 288 participants; two studies were fully published and five were published as abstracts.
  • The authors obtained data for two studies published as abstracts from authors; these two abstracts and the two full papers contributed to meta–analysis.
  • No study specified COPD diagnostic criteria and only one specified exacerbation criteria.
  • Short course treatment varied between three and seven days and longer duration 10 to 15 days, at equivalent daily doses of corticosteroids; five studies used oral prednisolone (dose 30 mg, four studies, one tapered dose) and two studies used intravenous corticosteroid treatment.
  • Mean ages of participants ranged from 64 to 73 years.
  • The authors assessed the risk of allocation and blinding bias as low for these studies.
  • Primary outcomes: risk of treatment failure did not differ significantly by treatment duration, but the confidence interval (CI) was too wide to conclude equivalence (odds ratio (OR) 0.94, 95% CI 0.38 to 2.36) (three studies, n = 158).
  • Forced expiratory volume in 1 second (FEV1) did not differ significantly when measured up to seven days (mean difference (MD) 0.07 L, 95% CI 0.19 to 0.05) or after seven days (MD 0.02 L, 95% CI 0.10 to 0.06) (four studies, n = 197).
  • The likelihood of an adverse event (four studies, n = 102) did not differ significantly by treatment duration, but again the CI was wide (OR 0.58, 95% CI 0.14 to 2.40).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pulmonology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pulmonology Articles

1 Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): A randomised, double-blind, placebo-controlled trial The Lancet Respiratory Medicine, May 15, 2014    Clinical Article

2 Value of different bronchoscopic sampling techniques in diagnosis of sarcoidosis: A prospective study of 151 patients Journal of Bronchology & Interventional Pulmonology, July 21, 2014    Clinical Article

3 Effects of yoga training in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis Full Text Journal of Thoracic Disease, July 7, 2014    Free full text    Evidence Based Medicine

4 Serial chitotriosidase measurements in sarcoidosis - Two to five year follow-up study Respiratory Medicine, May 30, 2014    Clinical Article

5 Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial The Lancet Respiratory Medicine, March 6, 2014    Clinical Article

6 Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia JAMA, June 4, 2014    Evidence Based Medicine    Clinical Article

7 Multicentric study on the beta-blocker use and relation with exacerbations in COPD Respiratory Medicine, June 19, 2014    Clinical Article

8 Fruit and vegetable intake and risk of wheezing and asthma: A systematic review and meta-analysis Nutrition Reviews, July 1, 2014    Evidence Based Medicine

9 Twice daily N-acetylcysteine 600mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): A randomised, double-blind placebo-controlled trial The Lancet Respiratory Medicine, January 30, 2014    Clinical Article

10 Chronic Cough: An Update Mayo Clinic Proceedings, October 3, 2013    Review Article    Clinical Article

11 Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: Impact on survival and bacterial resistance Critical Care, November 8, 2013    Clinical Article

12 Regadenoson use in patients with chronic obstructive pulmonary disease: The state of current knowledge Full Text International Journal of COPD, January 23, 2014    Free full text    Review Article    Clinical Article

13 Glucocorticoid-resistant asthma Journal of Asthma, December 4, 2013    Clinical Article

14 The use of N-acetylcysteine in respiratory diseases Current Respiratory Medicine Reviews, July 17, 2014    Review Article

15 Repeated dyspnea score and percent FEV1 are modest predictors of hospitalization/relapse in patients with acute asthma exacerbation Respiratory Medicine, July 25, 2014    Clinical Article
Exclusive Author Commentary

16 A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD Respiratory Medicine, July 10, 2014    Clinical Article

17 Effect of early versus late or no tracheostomy on mortality of critically ill patients receiving mechanical ventilation: A systematic review and meta-analysis The Lancet Respiratory Medicine, July 8, 2014    Evidence Based Medicine    Clinical Article

18 Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: A pooled analysis of four clinical trials Full Text International Journal of COPD, July 28, 2014    Free full text    Clinical Article

19 Montelukast for prevention and treatment of asthma exacerbations in adults: Systematic review and meta-analysis Allergy and Asthma Proceedings, July 7, 2014    Evidence Based Medicine    Review Article

20 Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis European Respiratory Journal , July 28, 2014    Clinical Article

Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicinemore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close